Io Biotech Inc (IOBT) Annual Balance Sheets

Annual · GAAP · USD millions
Access IOBT quarterly Balance Sheets →
This page allows investors to track Io Biotech Inc's balance sheet development across multiple reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent60.03
Cash & Short-term Investments60.00
Prepaid Expense And Other Assets Current4.92
Total Current Assets64.95
Equipment/Property/Plant Net0.64
Other Assets, Noncurrent2.00
Restricted Cash Noncurrent0.27
Operating Lease Right Of Use Asset1.73
Total Assets67.70
Liabilities
Accounts Payable, Current AC4.66
Accrued Liabilities And Other Liabilities14.11
Other Liabilities, Current0.72
Total Current Liabilities19.49
Total Long-term Debt0.00
Other liabilities, Noncurrent1.20
Operating Lease Liability Current0.72
Operating Lease Liability Noncurrent1.20
Total Liabilities20.68
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock413.11
Retained Earnings / Accumulated Deficit-359.31
Other Equity-6.85
Common Stockholder's Equity47.02
Total Stockholder's Equity47.02
Liabilities & Stockholder's Equity67.70
4 historic quarters locked

Sign in to unlock the full Io Biotech Inc balance sheet history.

About Io Biotech Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-047744

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License